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“Cytology should be considered a further dimension of pathology. Cytology 
and histology are not mutually exclusive. In the hands of competent 
cytopathologists a combination of cytology and histology yields the highest 
percentage of accuracy resulting in the earliest possible diagnosis of oral 
carcinoma.”  
                                                                   Salvatore R. Allegra, 1973 
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Abstract 
Background and Aims 
While a single “high quality” oral liquid based cytology (LBC) study has shown a high 
sensitivity and specificity for the technique in detection of oral dysplasia and malignancy, the 
high unit cost of this technology cannot be borne by the developing African countries. This 
study aims to evaluate the efficiency of an alternative cost-effective technique, Shandon 
PapSpin (PS) LBC in diagnosis of oral and oropharyngeal dysplasia and malignancy.    
Materials and Methods 
We compared the diagnostic accuracy of Shandon PS LBC with that of scalpel biopsy in 69 
patients. Transepithelial cytology specimens were obtained using a cervical Cytobrush. The 
cytology specimens were graded and scored using a novel oral cytologic grading and scoring 
system respectively. 
Results 
 
Histological diagnosis of dysplasia or invasive squamous cell carcinoma was made in 51 of 
the 69 cases. Histology confirmed the cytological diagnosis of dysplasia or malignancy in 49 
of the 51 cases. There were two false negative and no false positive cases. The sensitivity was 
96% and the specificity 100%. The cytologic grade correlated positively with histologic 
grade. The best cut off value for distinguishing reactive/mildly dysplastic lesions from high 
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grade/invasive squamous cell carcinoma was determined as a cytologic score of 3, 
representing a sensitivity of 95% and a specificity of 96%. 
Conclusion 
The Shandon PS LBC in association with transepithelial brush biopsy technique (TBBT) is a 
highly sensitive, specific and economical screening test in detection of oral and oropharyngeal 
dysplasia and malignancy. The proposed oral cytologic grading system correlates well with 
histology. The novel oral cytologic scoring system shows promise as a simple, reliable and 
reproducible scoring system. In addition, the liquid residual allows for immunocytochemical 
(Podoplanin) testing. 
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Introduction 
 
Oral cancer is a serious and escalating problem in many parts of the world. It is the sixth most 
common cancer globally (Warnakulasuriya, 2010).  The annual estimated incidence is around 
500,000 with 275,000 for oral and 130,300 for pharyngeal cancers,  two thirds of these cases 
occurring in developing countries including South Africa (Ferlay, Pisani, Parkin, 2004). 
Despite advances in the field of oncology and improvements in surgical techniques, 
investigators frequently report a 5 year survival rate of 50% (Ferlay et al., 2004). There is 
some evidence that early diagnosis and treatment improves the long term survival and can 
dramatically decrease morbidity associated with treatment (Peacock, Pogrel, Schmidt, 2008). 
This calls for an urgent adoption of a national, economical and practical screening test for oral 
cancer with minimal false positive and false negative results. 
 While tissue biopsy is a time consuming, uncomfortable and relatively expensive procedure 
that cannot be applied to the general population, exfoliative cytology is a simple, non-invasive 
and time-saving technique which collects atraumatically a rich concentration of cells over a 
much wider area  (Glennie, Gilbert, Melcher, Linehan, Wadsworth, 1976). 
During the 1960’s and 1970’s, oral cytology became popular (Umiker, Lampe, Rapp, Hinker, 
1960; Hayes, Berg, Ross, 1969; King 1971; Allegra, Broderick, Corvese, 1973), but soon it 
was largely abandoned and the popularity was short lived.  
The lack of interest in oral cytology is due to a high percentage of false negative diagnoses, 
attributed to great variation in technical quality and cellularity of oral smears as well as the 
sampling procedure. Recent advances in cytological procedures have led to the emergence of 
 
 
 
 
11 
 
 
 
liquid based cytology. This technique significantly enhances the quality of the smears by 
reducing necrosis, blood and inflammation and yields slides with high cellularity. 
While LBC is currently the primary means of cervical processing in the western world 
(Powell, Smith, Filander, 2006), the high unit cost of this technology cannot be borne by the 
developing African nations due to the limited budget allocated to the health care system.  This 
led to the development of an alternative, cost effective and competent procedure based on 
cytocentrifugation, the Shandon PS LBC technique. 
Although a few studies have demonstrated the value of automated LBC techniques, 
particularly Thin Prep, in detection of oral and oropharyngeal (pre) malignancy, to date there 
are no reports on the potential applications of Shandon PS LBC oral test.  
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Literature Review 
Basic facts about oral cancer 
Oral cancer is a serious and escalating problem in many parts of the world.  It is the sixth 
most common cancer globally (Warnakulasuriya, 2010). The annual estimated incidence is 
around 500,000, with 275,000 for oral and 130,300 for pharyngeal cancers, two thirds of these 
cases occurring in developing countries including South Africa (Ferlay, Pisani, Parkin, 2004).  
There is a wide geographical variation in the incidence of this cancer. Data on oral cancer in 
the African continent is very little and limited to few hospital cancer registries (Moore, 
Johnson, Pierce, Wilson, 2000; Warnakulasuriya, 2010).   Based on the data collected by the 
national cancer registry, oral cancer in all South African females and males accounted, 
respectively, for 1.8 per cent and 5.0 per cent of all cancers (Hille, Shear, Sitas, 1995).  A high 
incidence was noted in black, coloured and white men, while females were affected more 
frequently in the Asian population. The incidence was particularly high in coloured men 
(13.13), which was substantially higher than the figure of 8.8 reported in 1979 (Hille et al, 
1995).  
Despite advances in the field of oncology and improvements in surgical techniques, 
investigators frequently report a 5 year survival rate of 50% (Frelay et al., 2004). The most 
important factor affecting survival is the cancer’s stage (McGurk, Chan, Jones, O’Regan, 
Sherriff, 2005).  In a recent study, the five year disease-specific survival rate for stages I-III 
fell from 96 to 78%, but survival for stage IV disease was only 57% (Rogers, Brown, 
Woolgar, 2008). Many oral cancers present at a late stage and patients continue to delay 
visiting their clinicians until their disease has reached an advanced stage. There is some 
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evidence that early diagnosis and treatment improves the long term survival and can 
dramatically decrease morbidity associated with treatment (Peacock, Pogrel, Schmidt, 2008).  
A suitable screening test for oral cancer 
 Screening via visual inspection alone has resulted in poor detection rates (Peacock et al, 
2008).  Biopsy is a time-consuming, uncomfortable and relatively expensive procedure that 
cannot be applied to the general population. Even though for the last 100 years, biopsy has 
remained the “gold standard” and principle method of tissue diagnosis, the technique presents 
major limitations (Hopper, Kalavrezos, 2007). In large lesions, selecting the most appropriate 
site of biopsy remains a major challenge to the clinician.  In medically compromised patients, 
particularly those on anticoagulant therapy (e.g. Warfarin), biopsy may have disastrous and 
catastrophic consequences (Hopper et al, 2007).  Of particular concern is the great inter- and 
intra-examiner variability in the interpretation of oral epithelial dysplasia, which may 
undermine the trust in histological assessment (Warnakulasuriya, 2008).   
On the other hand, exfoliative cytology is a simple and non-invasive technique, which adds no 
significant time to the routine clinical examination procedure. It collects atraumatically a rich 
concentration of cells over a much wider area, so that a small focus of malignancy is less 
easily missed.  The technique may be employed usefully in combination with histology and is 
generally well-tolerated by the patient (Glennie, Gilbert, Melcher, Linehan, Wadsworth, 
1976). 
The rise and fall of oral cytology 
In 1860 Beale published the first report on cytological evaluation of exfoliated oral and 
pharyngeal epithelial cells. In 1941, Papanicolaou and Traut demonstrated the diagnostic 
value of exfoliative cytology in detection of the carcinomas of the uterine cervix.  
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Subsequently a number of studies were carried out in the cytological diagnosis of dysplastic 
and malignant lesions in that site and elsewhere in the body. During the 1960’s and 1970’s, 
oral cytology became popular (Umiker, Lampe, Rapp, Hinker, 1960; Hayes, Berg, Ross, 
1969; King 1971; Allegra, Broderick, Corvese, 1973), but soon it was largely abandoned and 
the popularity was short-lived.  
 On the contrary, the Pap smear has been shown to be an inexpensive and reliable screening 
test for cervical cancer and has been ranked by cancer epidemiologists as one of the top three 
contributors to public health (Rosenthal, Geddes, Trimble, Carson, Allie, 2006). This 
disparity may be explained partly by the difference in natural history of the two cancers and 
the lack of a definitive risk factor for oral squamous cell carcinoma (OSCC).  Most cervical 
cancers take from 8 to 10 years to develop from first HPV infection and therefore the natural 
history of the disease enables the detection of most lesions at an early stage, even after 1 or 2 
missed opportunities because of under-interpreted Pap smears (Rosenthal et al., 2006).  In 
addition, a clear-cut transformation zone from which the cervical lesions develop does not 
exist in the oral cavity. 
However, the lack of interest in oral cytology needs a more solid explanation and can be 
attributed to a high percentage of false negative diagnoses (Nichols et al. 1991; Kaugars, 
Silverman, Ray, 1998). A negative result may unnecessarily defer the definitive diagnosis 
with associated poor outcome (Potter, Summerlin, Campbell, 2003).   
Some early investigators (Umiker et al., 1960; King, 1971; Hayes et al., 1969; Allegra et al, 
1973) found oral cytology a reliable and sensitive diagnostic tool, while others (Chandlre, 
1966; Shklar, Cataldo, Meyer, 1970; Selbach, Von Haam, 1963; Cooke, 1963; Folsom, White, 
Bromer, Canby, Garrington 1972) were more critical and less enthusiastic regarding the 
reliability of cytologic screening, especially when compared with biopsy results.  Shklar et al 
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(1970) particularly reported a relatively high false negative rate (13.7%) in a study of 3657 
simultaneous cytologic and histologic examinations.  
The early investigators acknowledged the major limitations of oral cytology and strove to 
improve the quality of the smears and the sampling procedure by modifying the collecting 
implements, in an attempt to decrease the number of false negative results.   
 Collecting instruments in oral exfoliative cytology 
A number of instruments have been used and assessed in cervical screening. These include the 
cotton tip applicator, wooden spatula (wooden tongue depressor), Cytobrush, Ayre spatula, 
Cervex Brush and multispatula.  Such a variety is less common with oral cytology (Ogden, 
Cowpe, Green, 1992).  The most commonly used instruments in oral exfoliative cytology are 
the wooden tongue depressor and the Cytobrush.  
The wooden spatula has been shown to be an effective, inexpensive and readily available 
instrument in obtaining cells from both normal and diseased oral mucosa (Cowpe, Longmore, 
Green 1985; Cowpe, Longmore, Green, 1988). However, there may be clumping of the cells 
with reduction in quality of smears (Ogden, Cowpe, Green, 1992). Its porous and absorptive 
nature prevents adequate transfer of cellular material from the spatula to the glass slide 
producing paucicellular and non-representative smears.  More importantly, the wooden 
spatula lacks adequate flexibility in collecting diagnostic cells form areas of the oral cavity 
difficult to reach, such as the ventral surface of the tongue (Jones et al., 1994).  
The Cytobrush has become the standard instrument in screening for cervical neoplasia. 
Several authors have consistently shown the relatively high sensitivity of Cytobrush in 
diagnosing dysplastic lesions of the uterine cervix and have recommended it to replace the 
traditional endocervical curettage (ECC) in follow up of patients with abnormal Pap smears 
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(Weitzman, Korhonen, Reeves 1988; Frost, 1992; Mogensen et al., 1997).  In a comparative 
study by Mogensen et al, the Cytobrush provided sufficient material for cytologic evaluation 
in nearly all cases (vs. 12% in the ECC group), reducing the number of re-examinations and 
increasing economical costs. The Cytobrush was also found to be less inconvenient to the 
patient.  
In a study to compare the efficiency of Cytobrush with that of the wooden spatula, Ogden et 
al (1992) found the Cytobrush statistically more efficient than the wooden spatula in terms of 
both cell yield and cell dispersion, frequently associated with better quality smears. The 
flexible nature of the Cytobrush allowed ease of collection from less accessible areas, 
particularly the ventral surface of the tongue. A poor cell yield was associated with smears 
from the palate for both instruments. The study failed to analyse the value of these 
instruments in samples from abnormal oral mucosa, particularly in hyperkeratotic/leukoplakic 
lesions.  
In a similar comparative study by Jones et al (1994), both instruments were found to collect 
an adequate number of epithelial cells and elicit a mild degree of patient discomfort. 
However, the application of Cytobrush was found to be more desirable, as it resulted in an 
even distribution of epithelial cells, with improved diagnostic outcome. Furthermore, the 
flexible plastic handle allowed easy access to intraoral locations difficult to reach, making it 
currently the best instrument for oral exfoliative cytology.  
In a study of normal oral mucosa using the liquid based cytology (LBC) technique (Kujan et 
al., 2006), brushing the lateral border of the tongue with a Cytobrush caused a mild degree of 
discomfort in a reasonable proportion of the participants. Pain was felt by 8% of the subjects, 
but it was hypothesized that the tongue thrust rather than the actual rubbing of the brush itself 
was responsible for the perceived pain (Kujan et al., 2006). The authors experienced some 
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difficulty in using the cervical Cytobrushes with respect to their size and shape and 
recommended the development of a Cytobrush suitable for oral sites with optimal size and 
bristle geometry (Kujan et al., 2006). 
In a recent LBC study, remarkable results were obtained, using a disposable dermatological 
curette to sample potentially malignant lesions of the oral mucosa (Navone et al, 2007).   
 The transepithelial brush biopsy technique   
While the Cytobrush appears to be an ideal instrument in oral exfoliative cytology, access to 
the deeper cell layers may prove difficult or impossible in some cases, particularly in thick 
hyperkeratotic/leukoplakic lesions.  This is of particular concern, since many dysplastic cells 
are first detected in the basal cell layer, and the diagnostic cytomorphologic features may be 
lost as the cells mature towards the surface and parakeratin and keratin are produced 
(Mehrotra, Gupta, Singh, Ibrahim, 2006).   
In a study of normal oral mucosa using Thin Prep LBC technique, only 6 of 150 slides studied 
contained basal cells (Kujan et al., 2006). 
In earlier studies and in the quest to find an ideal instrument capable of collecting a 
representative population of superficial, intermediate and basal cells, sharp/abrasive 
instruments (e.g. metal spatula, sharp spoon, amalgam spatula) were employed (Sandler, 
1964; Allegra et al., 1973).  Although the invasive nature of these implements contribute to a 
more representative sample of cells with improved results, the essential advantages of 
cytology when compared with biopsy are lost (Mehrotra, Hullmann, Smeets, Reichert, 
Driemel, 2009). 
To overcome this deficiency, in 1999 the transepithelial brush biopsy technique (TBBT) was 
introduced (Sciubba, 1999; Christian, 2002; Drinnan, 2000). With TBBT, the brush is rotated 
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along the lesion a few times to provoke pin point (punctuate) bleeding. This ensures a full 
thickness epithelial sampling via a minimally invasive procedure.  In the first report on TBBT 
in a large scale study by the U.S. collaborative OralCDx study group, Sciubba et al (1999) 
reported zero false negative diagnoses.  
Subsequently, in a retrospective review of 115 cases in 2003, Potter et al reported a false 
negative rate of 3.5 % (4 of 115 cases) for the recently described technique. Since the 
technique provides adequate diagnostic cells for a correct diagnosis to be made, the authors 
concluded that the most likely probability may be that the technique inherently lacks adequate 
sensitivity to detect oral premalignant/malignant lesions (Potter et al., 2003).  However, the 
authors failed to provide any information about the technical quality of the smears.   
Moreover, many studies have shown that only a fraction (20%) of the available epithelial cells  
on the collecting device are deposited on the conventional glass slides and this may partly 
explain the high false negative rate associated with conventional cytology (CC) in general 
(Hutchinson et al., 1998). 
Liquid Based Cytology, improving quality, improving adequacy 
Recent advances in cytological procedures have led to the emergence of LBC, in an attempt to 
improve the sensitivity of conventional cytologic smears. In liquid based preparations, the 
collecting device is rinsed in a vial containing preservative fluid with even distribution, 
immediate fixation and significant retrieval of the sampled cells (Hutchinson et al., 1998).   
There are currently two well established automated LBC methods. The Thin Prep (Cytyc 
Corporation, Boxborough, MA) obtained clearance by the food and drug administration 
(FDA) in 1996, followed by the SurePath (BD TriPath, Burlington, NC) system, previously 
known as the AutoCyte Prep, in 1999. Since its introduction in the mid 1990’s, LBC has been 
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widely adopted as the primary means of cervical processing in the western world (Powell, 
Smith, Filander, 2006).  
Many studies have shown a dramatic decline in the number of inadequate specimens and 
improved screening time with LBC (Maccallini et al., 2008; Ronco et al., 2007; Laverty, 
Farnsworth, Thurloe, Grieves, Bowditch, 1997; Kujan et al., 2006; Navone et al., 2007). The 
technique greatly enhances the quality of the smears by effectively reducing bacterial counts 
and the number of inflammatory cells. Blood and air drying artefacts are eliminated.  
While there is consensus that LBC reduces the inadequacy rate and screening time and 
generates high quality specimens, the sensitivity and specificity of this modality versus CC in 
detection of cervical dysplasia and malignancy is a subject of controversy. The results of 
many comparative studies have been controversial and “high quality” studies are lacking 
(Taylor et al., 2006; Ronco et al., 2007).  
The majority of studies are based on a “split-sample” design and have failed to include a 
randomized controlled trial or utilize histology as the “gold standard” of diagnostic 
comparison (Hartmann, Nando, Hall, Myers, 2001).  
With a split sample design the collected specimen is first used to prepare conventional smears 
and the residual material is then transferred to the LBC collection fluid preservative. This 
leads to removal of the diagnostic cells by the conventional method, attenuating the diagnostic 
accuracy of the LBC technique (Ronco et al., 2007). This may partly explain the absence of 
the endocervical cells reported in cervical liquid based preparations. The endocervical cells 
are often trapped in mucus, and easily spread on a smear slide, in favour of CC (Weynand et 
al., 2003).  
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 In a review of new cervical cytologic techniques, none of the 962 articles fulfilled the 
predefined inclusion criteria and failed to include biopsy as the “gold standard” of diagnostic 
comparison (Hartmann et al., 2001).  
In a fairly recent large randomized clinical trial, Maccallini et al (2008) found no statistically 
significant differences in sensitivity and specificity of the two methods with only a slight 
increase in detection of high grade intraepithelial lesions in favour of LBC. The same study 
addressed the relatively high cost of thin layer preparations, which is not compensated for by 
the decrease in the number of inadequate specimens and improved reading time (Maccallini et 
al., 2008).  
In a large randomized clinical trial in South Africa, Taylor et al (2006) also found no 
statistically significant differences between the two methods in all four measures of test 
performance (sensitivity, specificity, positive predictive value and negative predictive value).  
However a substantial reduction in the number of “satisfactory but limited by…..” specimens 
was noted. The study concluded that the high unit cost of this technology may not be 
justifiable in less developed countries unless substantial improvements in test performance 
can be achieved with this method (Taylor et al., 2006).   
Oral liquid based cytology 
While numbers of papers on cervical LBC have been published, there have been very few 
studies on oral LBC. In one of the first few comparative liquid based cytologic studies in the 
oral cavity and using a split-sample design, Hyama et al (2005) reported a high diagnostic 
agreement between liquid based preparations and conventional smears in oral lesions. 
However, the thin-layer preparations demonstrated a statistically higher improvement in cell 
distribution (66%) and a substantial reduction in the presence of obscuring blood. Moreover, 
the number of inadequate specimens decreased and the cytomorphologic features were greatly 
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enhanced with optimal visualisation of viral cytopathic effects (e.g. HSV) and cytological 
abnormalities associated with squamous cell carcinoma (Hyama et al., 2005).  
Hyama and co-workers felt that although the use of automated LBC is desirable, the technique 
requires sophisticated laboratory equipment and well trained laboratory personnel. 
Nevertheless, the study failed to incorporate biopsy as the gold standard of diagnostic 
comparison, and the true sensitivity of the technique remains uncertain.  No mention of the 
brushing technique or the cytologic criteria used to assess the specimens was made in their 
study.  
In a study of normal oral mucosa using Thin Prep LBC technique, Kujan et al (2006) 
experienced high quality specimens. Even distribution of cells, reduced clumping of epithelial 
cells and a marked reduction in the number of polymorphs, bacteria and mucus were noted.  
This led to ease of interpretation and significant reduction in screening time. Only 2 out of 
150 specimens (1.3%) were considered inadequate (Kujan et al., 2006).   
In the one and only “high quality”  LBC study from Italy, LBC was shown to have a better 
sensitivity (95.1%) and specificity (99%) than conventional cytology (85.7% sensitivity & 
95.9% specificity) in the diagnosis of potentially malignant lesions of the oral mucosa, with 
fewer inadequate specimens, 8.8%  in LBC group versus 12.4% in CC group (Navone et al., 
2007).  
The Shandon PapSpin test  
 While it appears that a shift from CC to thin layer liquid based preparations is desirable in 
developed countries, especially by the availability of the sample for further diagnostic 
procedures (e.g. molecular studies and immunocytochemistry) (Powell et al., 2006), this is not 
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the case for underdeveloped/developing African countries, where the high cost of this 
technology cannot be borne by the limited budget allocated to the health care system.  
The high unit cost of automated LBC techniques led to the development of an alternative, 
manual, cost effective and competent cytoprepratory method based on cytocentrifugation.  
The technique utilizes the most common and readily available laboratory equipment, the 
Shandon cytospin, while generating a cytologic sample of cells, easily interpreted using 
traditional and well known cytomorphologic criteria (Rosenthal et al., 2006). 
 The Shandon cytospin has been the main feature and integral component of many 
laboratories for 30 years. Body fluids have been processed successfully using this inexpensive 
equipment.   
In the first landmark comparative study using the new Shandon PS LBC technique Weynand 
et al (2003) found no major differences in test performance between the new technique and 
conventional smears.  However, the PapSpin (PS) produced excellent quality smears with a 
dramatic reduction in the “satisfactory but limited by…” specimens in a proportion of 1:5 in 
favour of PS. Blood was not a feature in all PS samples. An even distribution of cells was 
observed with fewer thick cellular aggregates. The inflammatory cells were preserved but 
failed to obscure the squamous elements. HPV testing was made possible using the PS 
collection fluid (Weynand et al., 2003).  
Weynand and associates also reported a marked difference in the detection rate of fungal 
infections in favour of PS and concluded that the PS performance is equivalent to the 2 FDA 
approved automated LBC procedures but that the new technique eliminates the need for 
expensive equipments to prepare slides, making it a cost-effective alternative for LBC in 
cervical cancer screening. The authors acknowledged the lack of endocervical cells in a high 
percentage of their PapSpins because of the splitting of the sample (Weynand et al., 2003).  
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In a subsequent comparative study designed to optimize the new technique, Rosenthal et al 
(2006) confirmed the earlier observations reported by Waynand et al (2003) and mentioned 
that the new technique not only improves the screening time but effectively lowers the 
processing time (Rosenthal et al., 2006). With this technique 48 PS samples can be processed 
in one hour, while 25 Thin Prep samples are processed in 1 hour using the expensive T2000 
equipment.  
They also emphasized the fact that PS interpretation is not hampered since traditional 
cytomorphology is maintained and the background is preserved but dramatically improved.  
Interestingly the same study found a high detection rate for low grade intraepithelial lesions. 
Koilocytes, which represent HPV-induced cytopathic changes, may be scanty in early low 
grade lesions and concealed by obscuring elements in conventional smears; however, they 
were readily visualized on PS (Rosenthal et al., 2006). 
 A fairly recent study demonstrated improved sensitivity for the PS vs. CC (78.1% vs. 68.7%) 
in the split-sample group (Rimiene et al., 2010). The authors also reported a low inadequacy 
rate and improved screening time. A higher detection rate was also noted for high and low 
grade intraepithelial lesions.  
While the PS proves to be an affordable and cost effective alternative to automated LBC 
techniques, its superiority to CC requires further validation through “high quality” studies.  
Our study was designed to evaluate the diagnostic accuracy of Shandon PS LBC technique in 
diagnosis of oral and oropharyngeal dysplasia and malignancy. Although a few studies have 
demonstrated the value of automated LBC techniques, particularly Thin Prep, in detection of 
oral and oropharyngeal premalignancy and malignancy, to date there are no reports on the 
potential applications of Shandon PS LBC oral test.  
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Methodology 
Aim 
To evaluate the efficiency of Shandon PS LBC technique in diagnosis of dysplastic and 
malignant lesions of the oral and oropharyngeal mucosa. 
Objectives 
 To obtain trans-epithelial cytology specimens of part of the mucosal 
dysplastic/malignant lesions using a cervical Cytobrush. 
 To obtain scalpel biopsy specimens on the remainder of the lesion under local 
anaesthesia. 
 To compare findings obtained by Shandon PS LBC technique with the findings of 
paraffin section histopathology. 
Hypothesis 
The Shandon PS LBC technique will prove to be a highly sensitive and specific method in the 
diagnosis of dysplastic and malignant lesions of the oral and oropharyngeal mucosa. 
Study Design 
Cross-sectional designs involve the collection of data at one point in time: the phenomena 
under study are captured during one period of data collection. Cross-sectional studies are 
appropriate for describing the status of phenomena or for describing relationships among 
phenomena at a fixed point in time (Polit 2004). Since this study involves comparing the 
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findings obtained by Shandon PS LBC technique with that of paraffin section histopathology 
within a defined period of time, a cross-sectional design best facilitated this process. 
Participants 
Selection criteria 
Inclusion criteria 
 All patients with suspicious dysplastic/malignant lesions of the oral and oropharyngeal   
mucosa. 
 All patients that present at diagnostic services of the Ear, Nose and Throat department -
Tygerberg Hospital, Oral Health Centres - University of the Western Cape (UWC) and the 
Head & Neck Oncology Combined Clinic, Groote Schuur Hospital, University of Cape Town 
(UCT). 
 10 patients with reactive/benign alterations of the oral and oropharyngeal mucosa as 
part of the control group. 
 
Exclusion criteria 
 Benign/reactive alterations of the oral and oropharyngeal mucosa will not be included. 
 Deep mucosal abnormalities. 
Sampling method 
Non probability purposive sampling was used for this study. Non probability purposive 
sampling is based on the belief that researcher’s knowledge about the population can be used 
to hand-pick sample members. In this method the researcher purposely selects participants 
who are judged to be typical of the population (Polit 2004). For the current study the 
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researcher purposely selected a group of participants who met the inclusion criteria. As a 
result, a non probability purposive sampling best facilitated this study. 
 
Sample size 
A series of 70 patients who had to undergo a routine tissue biopsy for the diagnosis of 
suspected dysplastic/malignant lesions of the oral and oropharyngeal region were included in 
the study. Suitable patients were selected from diagnostic services of the Ear, Nose and Throat 
department -Tygerberg Hospital, Oral Health Centres - University of the Western Cape (UWC) and 
the Head & Neck Oncology Combined Clinic, Groote Schuur Hospital, University of Cape Town 
(UCT). 
Procedure 
Written informed consent was obtained from each patient and comprehensive information 
about the study was conveyed to the patient. The protocol, informed consent and patient 
information forms were approved by the Universities of the Western Cape (UWC), 
Stellenbosch (US) and Cape Town (UCT).  
The sampling procedures took place in either of the respective outpatient clinics. The patient’s 
oral cavity and pharynx was inspected by direct oropharyngeal examination. The sessions 
consisted of an experimental and a routine diagnostic component. The experimental part of 
the study consisted of obtaining transepithelial cytology specimens. This was immediately 
followed by the routine diagnostic part in which biopsy specimens on the remainder of the 
lesion and/or the direct adjacent mucosal area were obtained under local anaesthesia.  
The cytology specimens were collected using a Cytobrush. The brush was rotated along the 
lesion a few times to elicit pin point (punctuate) bleeding (Fig 1). The idea was to harvest 
superficial, intermediate and basal cells (transepithelial specimen). The brush was then 
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immersed and gently rinsed in a vial prefilled with 3 ml of Shandon CytoRich® Red 
Collection Fluid preservative (Fig 2). The vial was labelled with appropriate patient 
identification data (Date of Birth, Hospital number, Sex, Name, Surname and Date of 
sampling). 
 
   Fig 1. The Cytobrush is rotated along the lesion                        Fig 2. The Cytobrush is immersed and gently   
   a few times to provoke pin point bleeding.                                 rinsed in CytoRich® Red Collection Fluid. 
 
Once it was in the cytology laboratory, the specimen was registered and allocated a cytology 
(STC) number by an independent cytotechnologist. The specimen vial then was pre-
centrifuged at 1500 revolutions per minute for 10 minutes. The supernatant was discarded and 
the sediment was agitated by a vortex mixer for approximately 10 seconds. An equal amount 
of fresh preservative (3 ml) was added to the sediment and the suspension was homogenized 
by a vortex mixer for approximately 10 seconds. Immediately, 4-5 drops of the cellular 
suspension were pipetted into the EZ Cytofunnel assembly (Fig 3).  
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Fig 3. The EZ Cytofunnel (Left) produces a 
28 mm
2
 circle of cells. The Megafunnel (Right) was 
developed to capture more cells (294 mm2). From Rosenthal 
et al. (2006). 
                                                                                                
          
 Fig 4. Shandon Cytospin® 4 cytocentrifuge                     Fig 5. EZ Cytofunnel assembly loaded 
                                                                                            into Shandon Cytospin® 4 cytocentrifuge    
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The assembly was capped; the hub was sealed with the protective lid and loaded into a 
Shandon Cytospin® 4 cytocentrifuge (Figs 4 and 5). 
Centrifugation at 1000 revolutions per minute for 5minutes at ‘medium’ acceleration 
deposited the cellular specimen onto a screening area of a glass slide to produce a circle of 
cells (28 mm
2
).  The slide was removed from the EZ Cytofunnel assembly, spray fixed, and 
stained with Papanicolaou stain. Each slide was protected by a glass coverslip. A summary of 
the procedure for the preparation of cytological specimens with CytoRich® Red Collection 
Fluid is provided in Diagram 1. 
The histology specimens were fixed in 10% buffered formalin and sent to the histopathology 
laboratory for routine H & E processing. 
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     Diagram 1. Protocol for the preparation of cytological specimens with  
     CytoRich® RedCollection Fluid. 
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Data Analysis 
Appropriate descriptive statistics were used to determine the statistical significance of the- 
Sensitivity= (true positive)/ (true positive +false negative), Specificity= (true negative)/ (true 
negative+false positive) -Shandon PS LBC method. The optimal cut-off value for 
distinguishing reactive/low grade lesions from high grade/invasive squamous cell carcinoma 
was sought by receiver operating characteristic (ROC) curves, which were generated by 
calculating the sensitivity and specificity of the cytologic scores at several predetermined cut-
off points. 
Evaluation 
The cytology slides were evaluated independently and blindly by a senior cytopathologist and 
an oral pathology registrar. A specimen was considered inadequate if less than 30% of the 
diameter of the circle (28mm
2
) was covered by cellular material. Since no standard oral 
cytologic grading system is currently in use, we propose a novel cytologic grading system 
suitable for use in the oral and oropharyngeal region, adapted from the Bethesda system for 
reporting cervical/vaginal cytology (Table 1). 
Given that there have been no studies on cytologic scoring in oral squamous cell carcinoma 
and to further validate the newly proposed classification scheme and discover the best cut off 
value for distinguishing recative/low grade lesions from high grade/invasive squamous cell 
carcinoma, we developed a novel scoring system, based on 9 cytologic characteristics. Each 
feature was scored separately, as shown in Table 2. 
The histopathology specimens were evaluated independently and blindly by a senior oral 
pathologist and registrar.  A histological diagnosis was reported on the basis of the Squamous 
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Intraepithelial Neoplasia (SIN) system.  The lesions were classified as:  absence of dysplasia, 
SIN I (mild epithelial dysplasia), SIN II (moderate epithelial dysplasia), SIN III (severe 
epithelial dysplasia/carcinoma in situ) and invasive SCC.  
 
Grading System 
A: Normal 
B: Reactive*  
C:Atypical - probably reactive/low grade   
D:Atypical - probably high grade  
E: High grade squamous intraepithelial lesion 
 
                                       (a) <10 cells/400x field 
                                       (b) >10 cells/400x field  
                           
F: Invasive squamous cell carcinoma  
  
                                        (a) <10 cells/400x field                  
                                        (b)  >10 cells/400x field 
G: Other Neoplasms: Specify. 
Table 1. Oral/Oropharyngeal cytologic grading system 
*The reactive category includes inflammatory, infective, repair & chemo/radiation changes. 
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Scoring System 
Irregular nuclear membrane                   Yes (1) / No (0) 
Irregular chromatin distribution             Yes (1) / No (0) 
Prominent nucleoli                                  Yes (1) / No (0) 
Abnormal cell shapes*                            Yes (1) / No (0) 
Parakeratotic cells**                               Yes (1) / No (0) 
Necrosis                                                   Yes (1) / No (0) 
Syncytial groups (>10 cells) ***             Yes (1) / No (0) 
Irregular nucleoli                                     Yes (1) / No (0) 
Abnormal cytoplasmic fragments            Yes (1) / No (0) 
Table 2 Oral/Oropharyngeal cytologic scoring system 
**Parakeratotic cells: Cells with dense orangeophilic cytoplasm and small hyperchromatic 
 degenerate nuclei. The nuclear-to-cytoplasmic ratio is low. 
 
*Abnormal cell shapes:  Abnormally configured keratotic cells with spindling, tadpole shapes 
or long cytoplasmic projections. 
***Syncytial groups: Pleomorphic cells seen in three-dimensional clusters. 
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Ethical Issues 
The selected patients were appropriately informed and counselled before the diagnostic 
biopsy procedure on the proposed additional cytology procedure which took place in the same 
session and their voluntary participation elicited by signing a consent form (Please see patient 
information/consent forms, Appendix).  
The patients were assured that they were not subjected to additional harm (in that no extra 
tissue above the necessary was sampled for either cytology or histology purpose) and that 
they were allowed to withdraw anytime before the diagnostic procedure.  
Other than the routine confidentiality of the diagnostic procedure, the full confidentiality of 
the patients will be guarded by the researchers and nothing revealed in any presentations and 
publications. 
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Results 
Cytology Results 
A total of 70 cytology specimens were taken during the study. One specimen was considered 
inadequate as less than 30% of the diameter of the circle was covered by cellular material, 
resulting in an inadequacy rate of 1.42% (1 out of 70 cases).  This left 69 patients to form the 
basis for the current data analysis. Distributions of diagnostic categories, using the novel 
oral/oropharyngeal cytologic grading system were as follows: 4 within normal limits, 10 
reative, 6 atypical probably reactive, 4 atypical probably high grade, 5 high grade squamous 
intraepithelial lesions and 40 invasive squamous cell carcinomas (Table 3).  
 
Cytologic  Grade     Number of Cases  
A: Normal            4  
B: Reactive            10  
C: Atypical-probably reactive             6  
D: Atypical-probably high grade             4  
E: High grade lesion             5  
F: Invasive squamous cell carcinoma            40  
Total         n=69 
    Table 3 Cytology results 
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Fig 6. Reactive (inflammatory)-PapSpin from an aphthous ulcer- In addition to the normal 
 intermediate cells (Left), this image shows cells (Centre) with a generous body of  
mature cytoplasm and mild nuclear enlargement with an attendant slight increase in 
 nuclear to cytoplasmic (N: C) ratio. Hyperchromasia is not evident and the nuclear  
outlines are smooth. A squamous metaplastic cell is seen on the right. The cell shows 
 a marked increase in nuclear to cytoplasmic (N: C) ratio, resembling a high grade  
squamous intraepithelial lesion, but hyperchromasia is minimal and the nuclear outline 
 is smooth.  
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Fig 7. Reactive (Repair)-PapSpin from a healing erosive lesion on the palate in a patient with 
oral mucous membrane pemphigoid. The cells are arranged in a flat streaming sheet. 
The nuclei are enlarged and show smooth to slightly irregular nuclear outlines and single 
prominent nucleoli. Mild hyperchromasia is seen although chromatin structure and 
distribution remains finely granular. No single cells with similar cytomorphology were 
identified, a key feature to correct diagnosis. 
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Fig 8. Reactive (infective) - This image shows pseudohyphae of candida spp with a marked acute  
inflammatory cell response. The cell in the centre shows reactive cellular changes, mild  
nuclear enlargement with an attendant increase in N: C ratio. However, nuclear hyperchromasia  
is not present and the nuclear outline is smooth. 
 
 
Fig 9. Granuloma-PapSpin from an irregular ulcer with rolled/heaped up margins on the hard palate,  
clinically thought to be a squamous cell carcinoma. The image shows a cluster of epithelioid cells  
arranged in a syncytial fashion. The cells have oval to slightly bent nuclei and delicate cytoplasm. 
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Fig 10. Atypical-probably reactive/low grade. The cells in this image show nuclear 
enlargement , a slight increase in N:C ratio and slight nuclear hyperchromasia. 
The nuclear membranes are also slightly irregular in shape. Admixed neutrophils 
are  noted. Although the atypical squamous cells in this case may represent 
reactive change, a low grade squamous intraepithelial lesion cannot be complete 
ly excluded. 
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Fig 11.  Atypical-probably reactive/low grade. The cells in this image show nuclear enlargement  
with an attendant increase in N: C ratio, compare with the normal intermedaie cell nucleus seen 
 top right. The cells demonstrate irregularities of nuclear contours. The cytoplasm looks 
 slightly immature (more dense). Some neutrophil polymorphs are noted. The cell with the  
bright orangeophilic cytoplasm exhibits a degenerate nucleus. These atypical squamous cells 
 may represent a reactive change but a low grade squamous intraepithelial lesion cannot be 
 completely elxcluded. 
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Fig 12. Atypical-probably high grade.  A group of atypical squamous cells is seen in the centre.  
 The cells show variation in nuclear size. The nuclei are hyperchromatic and show 
 nuclear membrane irregularities. The nuclei are markedly enlarged compared with the 
 normal intermediate cell nuclei seen on the left, although  the nuclear-to-cytoplasmic ratio 
 is not quite as high as that seen in a high grade squamous intraepithelial lesion. 
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Fig 13. High grade squamous intraepithelial lesion- In this high grade lesion, the cells show high  
nuclear-to-cytoplasmic ratios and nuclear hyperchromasia with coarsely granular chromatin.  
The nuclear membranes are irregular, and the cytoplasm has a hard (dense) appearance. 
 
Fig 14. Invasive squamous cell carcinoma-Haphazard arrangement of variably-sized cells in a  
syncytial arrangement typical of carcinoma. This contrasts the streaming arrangement seen in  
repair. The nuclei demonstrate chromatin clearing, prominent irregular nucleoli and irregular  
nuclear outlines.  
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Fig 15. Invasive squamous cell carcinoma- an atypical keratin pearl, pathognomonic 
of keratinizing squamous cell carcinoma. 
 
 
 
 
Fig 16. Invasive squamous cell carcinoma- cell in cell (cannibalism). 
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Fig 17. Invasive squamous cell carcinoma- In addition to the carcinoma cells this image  
shows an abnormally configured keratotic cell with long cytoplasmic projections,  
bright pink cytoplasm, and intensely hyperchromatic irregular nucleus (bottom right). 
A parakeratotic cell and an abnormal cytoplasmic fragment are seen on the right. 
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Histology Results 
Distributions of diagnostic categories, using the SIN (Squamous Intraepithelial Neoplasia) 
classification system were as follows: Absence of dysplasia was seen in 18 cases, 0 SIN I, 1 
SIN II, 5 SIN III, 44 invasive squamous cell carcinomas and one case being classified as other 
neoplasm, Kaposi’s sarcoma (KS), (Table 4).  
 
Histology  Number of Cases  
Absence of dysplasia            18  
SIN I             0  
SIN II             1  
SIN III             5  
Invasive squamous cell carcinoma            44  
Other neoplasms             1  
Total          n=69  
Table 4. Histology results. 
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Cytohistological Correlation 
There were two false negative and no false positive cases (Table 5). The sensitivity of the 
Shandon PS LBC oral test was calculated to be 96%. The absence of false positive results 
produced a specificity of 100%.    
 
       Cytologic Grade  Number Of 
Cases 
Dysplasia/Malignancy      
On  Histology  
A: Normal              4                 1
*
  (SIN II)  
B: Reactive                                       10                 0  
C: Atypical-probably reactive                6                 1
*
  (KS)  
D: Atypical-probably  HG              4                 4  
E: High grade lesion              5                 5  
F: Squamous cell carcinoma             40                40  
Total           n=69               51  
Table 5. Cytohistological correlation 
*False negative cases. 
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Receiver Operating Characteristic Curve Analysis for Cytologic Scores 
Total cytologic scores were calculated for each case by the sum of the scores for individual 
cytologic features, and they were compared to the biopsy and cytology outcomes. The ROC 
(Receiver Operating Characteristic) curves for the cytologic scores are presented in Figs 18 
and 19. The optimal cut off point for distinguishing reactive/mildly dysplastic lesions form 
high grade/ invasive squamous cell carcinoma was determined as a cytologic score of 3, 
representing a sensitivity of 95% and a specificity of 96% for the cytology outcome (Table 6); 
and a sensitivity of 92% and a specificity of 94% for the biopsy outcome (Table 7). 
 
 
       Fig 18. Receiver operating characteristic curve analysis  
       for cytologic scores (cytology outcome vs. cytologic score). 
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# cases=69
1
sensitivity
2
1-specificity
3
specificity
4
pvp
5
pvn
6
score
Optimal cutoff
2
3
4
5
6
7
8
9
10
11
12
13
0.96 0.95 0.98 0.90 3
1.00 1.00 0.00 0.71 0
1.00 0.75 0.25 0.77 1.00 1
0.96 0.35 0.65 0.87 0.87 2
0.96 0.05 0.95 0.98 0.90 3
0.92 0.05 0.95 0.98 0.83 4
0.86 0.00 1.00 1.00 0.74 5
0.80 0.00 1.00 1.00 0.67 6
0.67 0.00 1.00 1.00 0.56 7
0.47 0.00 1.00 1.00 0.43 8
0.18 0.00 1.00 1.00 0.33 9
0.00 0.00 1.00 1.00 0.33
 
Table 6. Spreadsheet of cytologic scores vs. cytology outcome. 
pvp (positive predictive value). pvn ( negative predictive value). 
 
 
       Fig 19. Receiver operating characteristic curve analysis 
       for cytologic scores (biopsy outcome vs. cytologic score). 
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# cases=69
1
sensitivity
2
1-specificity
3
specificity
4
pvp
5
pvn
6
score
Optimal cutoff
2
3
4
5
6
7
8
9
10
11
12
13
0.92 0.94 0.98 0.81 3
1.00 1.00 0.00 0.74 0
1.00 0.72 0.28 0.80 1.00 1
0.92 0.39 0.61 0.87 0.73 2
0.92 0.06 0.94 0.98 0.81 3
0.88 0.06 0.94 0.98 0.74 4
0.82 0.00 1.00 1.00 0.67 5
0.76 0.00 1.00 1.00 0.60 6
0.65 0.00 1.00 1.00 0.50 7
0.45 0.00 1.00 1.00 0.39 8
0.18 0.00 1.00 1.00 0.30 9
0.00 0.00 1.00 1.00 0.30
 
Table 7. Spreadsheet of cytologic scores vs. biopsy outcome. 
pvp ( positive predictive value) pvn( negative predictive value). 
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Discussion 
The high unit cost of the automated LBC methods prompted us to evaluate an alternative cost- 
effective LBC method based on cytocentrifugation, the Shandon PS LBC technique. In our 
study we evaluated the efficiency of the PS as a reliable and economical screening test for 
oral premalignant/malignant lesions, utilizing biopsy as the gold standard of diagnostic 
comparison. To the best of our knowledge this is the first study, using the Shandon PS LBC 
technique in diagnosis of oral and oropharyngeal dysplasia and malignancy. Similar studies in 
cervical cancer screening have already been published with remarkably good results.   
In the current study, histology confirmed the cytological diagnosis of dysplasia/malignancy in 
49 of the 51 cases (Table 5). The sensitivity was 96% and the specificity was 100%. There 
were only two false negative and no false positive results.  Ideally, the two false negative 
cases should have been excluded from the study, as they did not conform to the study’s 
predefined sampling technique and exclusion criteria. However, inclusion of these two cases 
in the study underlines the importance of the transepithelial brush biopsy technique (TEBBT) 
and the major limitation of the oral brush biopsy in sampling deep mucosal abnormalities.  
Since its introduction in the late 1990’s, the TEBBT has shown to be a reliable cytologic 
technique for the detection of deeper epithelial abnormalities (Sciubba, 1999; Christian, 2002; 
Drinnan, 2000; Eisen, 2000). Only one retrospective study has reported a false negative rate 
of 3.5% (4/115) for the technique, but failed to acknowledge the association of conventional 
cytology with TEBBT as the most likely explanation for the false negative results (Potter et 
al., 2003).   
Many studies have shown that with CC only a fraction (20%) of the available epithelial cells 
on the collecting device is deposited on the conventional glass slides (Hutchinson et al., 
1998). Thus, it is possible that the diagnostic cells obtained by the TBBT in the study by 
 
 
 
 
51 
 
 
 
Potter et al (2003), never made their way onto the glass slides or if they did so the obscuring 
elements rendered them invisible. 
In one of our false negative cases, the thick hyperkeratotic/leukoplakic nature of the lesion did 
not permit the acquisition of a transepithelial cytologic specimen, as vigorous brushing did 
not provoke pin point (punctuate) bleeding. Only unremarkable superficial epithelial cells 
were sampled and reported as “Normal” on cytology.  The subsequent histology, however, 
revealed moderate epithelial dysplasia with atypical cells involving the deeper layers of the 
epithelium (Table 5).  
While the cervical Cytobrush appears to be an ideal instrument in oral exfoliative cytology 
(Ogden et al., 1992; Jones et al., 1994), particularly by its availability even in the less 
equipped primary health care settings, access to the deeper cell layers may prove impossible 
in some cases, particularly in thick hyperkeratotic/leukoplakic lesions.   
While, sharp instruments (e.g. metal spatula, sharp spoon, and amalgam spatula) have been 
shown to provide a representative sample of superficial, intermediate and basal cells with 
improved diagnostic outcome (Sandler, 1964; Allegra, 1973), the great degree of discomfort 
experienced by the patient makes biopsy with the scalpel under local anaesthesia a much more 
pleasant experience. Thus, in a thick hyperkeratotic/leukoplakic lesion, where a transepithelial 
brush biopsy is impracticable we recommend a scalpel biopsy under local anaesthesia as the 
diagnostic procedure of choice.  
Nevertheless, the cervical Cytobrush was capable of inducing pin point bleeding and 
generating an adequate and representative sample of cells in nearly all cases. The long and 
flexible plastic handles of the cervical Cytobrushes, allowed ease of collection from less 
accessible areas, particularly the oropharynx.  
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While brushing the lateral border of the tongue and floor of mouth was associated with a mild 
degree of discomfort, brushing the oropharynx (soft palate, base of tongue and tonsils) 
induced a choking sensation. This was simply prevented by spraying the oropharynx with a 
local anaesthetic (Xylotox 0.2%) prior to the transepithelial brushing procedure.   
In a recent LBC study, remarkably good results were obtained, using a disposable 
dermatological curette to sample potentially malignant lesions of the oral mucosa (Navone et 
al, 2007).  Although the invasive nature of this instrument results in adequate sampling of 
thick hyperkeratotic/leukoplakic lesions, its effectiveness over the more commonly used 
Cytobrush is yet to be proven.  The dermatological curette with its rounded metallic tip 
geometry may cause significant patient discomfort or result in suboptimal transfer of the 
sampled cells into the vial containing the liquid-based medium, increasing the number of 
inadequate specimens.  
In the other false negative case, the submucosal location and the nodular configuration of the 
lesion did not permit the cytological diagnosis of Kaposi’s sarcoma (Table 5).  Similarly, we 
do not advocate the use of a Cytobrush for the diagnosis of deep mucosal abnormalities, 
which is best confirmed on incisional/excisional biopsies under local anaesthesia.    
In the current study, the sensitivity (96%) and specificity (100%) of the PS closely 
approximates the sensitivity (95%) and specificity (99%) of the Thin Prep LBC procedure, 
reported by Navone et al (2007), in the one and only “high quality” oral LBC study.  
However, no false positive cases were reported in our study (0 vs. 3), which could potentially 
induce unwarranted anxiety in the patient, who must then undergo a second diagnostic 
procedure to confirm the true nature of the lesion.  
One of the advantages of LBC is the low inadequacy rate due to optimal cell fixation and 
significant retrieval of the sampled cells (Hutchinson et al., 1998). Our study’s inadequacy 
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rate (1.4%) is comparable to the inadequacy rate (1.3%) reported by Kujan et al (2006) in a 
study of normal oral mucosa using the Thin Prep LBC procedure, and is considerably lower 
than the inadequacy rates reported in the two fairly recent LBC studies utilizing the same 
technique, but in diseased oral mucosa, 6.8% by Hyama et al (2005) and 8.8% by Navone et 
al (2007).  
We obtained specimens of excellent quality with PS. Interpretation was not hampered since 
traditional cytomorphology was maintained; the background was preserved but dramatically 
improved. Blood was not a feature in all PS samples.  Bacteria and neutrophil polymorphs, 
which are essential for an appropriate diagnosis to be made, were present but failed to conceal 
the squamous elements (Fig 6).  An even distribution of epithelial cells was observed with 
few thick cellular aggregates. Dysplastic/malignant cells were optimally visualized (Figs 13 
and 14).  Infective organisms, in particular candida species were easily detected (Fig 8).  
Since no standard oral cytologic grading system is currently in use, we propose a novel 
cytologic grading system suitable for use in the oral and oropharyngeal region, adapted from 
the Bethesda system for reporting cervical/vaginal cytology. Our cytologic grading system 
correlates well with histology, and a correct cytological diagnosis was made in 49 of the 51 
histologically dysplastic/malignant lesions (Table 5). Therefore, the Shandon PS LBC is an 
effective tool for predicting the histologic grade. 
Given that there have been no studies on cytologic scoring in oral squamous cell carcinoma 
and to further validate the newly proposed classification scheme and discover the best cut off 
value for distinguishing recative/low grade lesions from high grade/squamous cell carcinoma, 
we tried to establish a simple and easy cytologic scoring method that could be applicable in 
routine cytologic diagnosis, based on 9 cytologic characteristics. We confirmed that a 
cytologic score of < 3 indicated a reactive/low grade lesion and a cytologic score of >3 
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indicated a high grade lesion or invasive squamous cell carcinoma (Figs 18 and 19), with high 
sensitivity (95%) and specificity (96%) (Table 6). While the scoring system shows promise as 
a simple, reliable and reproducible system, future large scale studies will have to confirm its 
applicability and usefulness and determine the optimal score for each cytologic diagnostic 
category.   
With the availability of new diagnostic methods, cytology is becoming an increasingly 
popular clinical technique, as a simple, rapid and comfortable procedure for obtaining 
diagnostic cells. One of the frequently cited advantages of LBC is that a considerable 
proportion of the sample is not used for cytology, and is thus available for molecular studies 
and immunocytochemistry (Powell et al., 2006). 
During the malignant transformation of cells the structure or expression level of some proteins 
may be altered (Yang et al, 2010). The relatively inexpensive Shandon PS LBC technique 
facilitates preparation of more than one slide for immunocytochemical analysis, to recognize 
and locate these cells.  
Patients with metastatic OSCC usually have a poor prognosis. The cell surface molecules 
involved in cell migration and invasion can be effectively utilized in surgical management of 
patients with OSCC and to predict the biologic behaviour of the lesion and the overall 5 year 
disease-specific survival.   
One such biomarker is Podoplanin (D2-40), a mucin-type transmembrane glycoprotein that is 
specifically expressed in lymphatic endothelial cells (Schacht, Dadras, Johnson, 2005).  It has 
been hypothesized that Podoplanin is able to effect tumour invasion by promoting tumour cell 
mobility (Raica, Cimpean, Ribatti, 2008).  A fairly recent histological study demonstrated that 
a high expression of Podoplanin (D2-40) by tumour cells is associated with high stage disease 
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(III and IV), the presence of lymph node metastases and poor outcome with 5 year disease- 
specific survival of only of 31% (Kreppel, Scheer, Drebber, Ritter, Zoller, 2010).  
Thus, this biomarker may be used to predict the presence of lymph node metastases in 
clinically N0 necks and the overall outcome of patients with OSCC.  It is hypothesized that 
Podoplanin may also have a place in treatment of patients with squamous cell carcinoma as 
knockdown of Podoplanin expression in squamous cell carcinoma has been shown to reduce 
tumour activity, increasing the susceptibility of tumour cells to commonly used 
chemotherapeutic agents in squamous cell carcinoma, such as Cisplatin and 5-Fluorouracil 
(Rahadiani et al., 2010). 
 While no identical cytologic studies exist in this respect we demonstrated that Podoplanin 
testing was made possible using CytoRich® Red Collection Fluid (Figs 20 and 21). However, 
future cytologic studies will have to confirm the real value of this biomarker in OSCC.    
 
 
Fig 20. High expression of Podoplanin (D2-40) by tumour cells. 
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Fig 21. High expression of Podoplanin (D2-40) by tumour cells. The normal intermediate cell  
on the right does not stain. Histology from the same patient 
showed high expression of Podoplanin and evidence of metastatic disease.  
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Conclusion 
The Shandon PapSpin LBC in association with transepithelial brush biopsy technique (TBBT) 
is a highly sensitive, specific and economical screening test in detection of oral and 
oropharyngeal dysplasia and malignancy. The Shandon PapSpin LBC procedure proves to be 
an affordable and cost-effective alternative to the currently available automated LBC 
techniques, particularly of use in developing African nations, where the high unit cost of the 
automated LBC methods is out of reach. 
The cervical Cytobrush is an ideal collecting implement for oral exfoliative cytology, capable 
of generating an adequate and representative sample of cells.  
The newly proposed oral cytologic classification system correlates well with histology, 
suitable for use in oral and oropharyngeal region. 
 The novel scoring system shows promise as a reliable and reproducible scoring system, 
however, future large scale studies will have to confirm its applicability and usefulness and 
determine the optimal score for each cytologic diagnostic category.   
Immunocytochemical (Podoplanin) testing was made possible using Shandon CytoRich® Red 
Collection Fluid. 
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University of the 
Western Cape 
 
Appendix 
 
 
 
 
 
Participant information leaflet and consent form 
 
Title of the research project: 
“Diagnostic accuracy of Shandon PapSpin liquid based cytology technique in diagnosis of 
oral and oropharyngeal dysplasia and malignancy.” 
UWC Ethics Reference Number: N09/01/51 
US Ethics Reference Number: N09/06/179 
Principal  Investigators:  Dr A Afrogheh (UWC), Dr Julie Wetter (UCT) 
Supervisors: Profs J.Hille (UWC) & CA Wright (US) 
Research Address: Ear Nose & Throat Surgical Services/Head & Neck Oncology Services 
of Groote Schuur Hospital/UCT Faculty of Health Sciences and NHLS Anatomical 
Pathology Laboratories, Tygerberg Hospital. Private Bag X1, 7505 Tygerberg - Cape Town, 
South Africa 
Contact Number: UCT/GSH Head & Neck Oncology Clinic 021-4044271  
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the 
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study staff or doctor any questions about any part of this project that you do not fully 
understand. It is very important that you are fully satisfied that you clearly understand 
what this research entails and how you could be involved. Also, your participation is 
entirely voluntary and you are free to decline to participate. If you say no, this will not 
affect your treatment negatively in any way whatsoever. You are also free to withdraw 
from the study at any point, even if you do initially agree to take part. 
This study has been approved by the Human Ethics Research Committees of the 
Universities of the Western Cape and Stellenbosch and will be conducted according to 
the ethical guidelines and principles of the International Declaration of Helsinki, South 
African Guidelines for Good Clinical Practice and the Medical Research Council 
(MRC) Ethical Guidelines for Research. 
What is this research study all about? 
 It is often necessary to take a biopsy in order to make a diagnosis when present with 
a non-healing ulcer or other problem in the mouth or throat. A biopsy involves 
cutting out a small section of tissue and is thus invasive. We would like to test a new 
diagnostic method which involves using a brush to wipe off cells which can be used 
to make a diagnosis. This method is much better and less uncomfortable. We would 
like to compare the new method with the current biopsy method to see if it is as 
good.  
Why have you been invited to participate? 
 You are about to undergo a necessary tissue sampling procedure (biopsy) to make a 
diagnosis of your lesion in the mouth or throat.  There is now the opportunity to test 
part of the lesion with this simple cytology brush method just before the tissue 
sample is taken of the same and immediate adjacent area and sent to the laboratory 
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for routine microscopic diagnosis.    
 We are asking you for permission to perform this additional cytology sampling 
procedure in the same operating session, just prior to the biopsy itself. The area of the 
cytology sampling will be included in the biopsy specimen.  
What will your responsibilities be? 
 Your responsibilities as a participant are solely passive and consist only of agreeing 
to allow us to perform the additional sampling of cells from the lesion in your mouth 
or throat during the same session, either in the clinics under local anaesthesia or in 
theatre under general anaesthesia.    
Will you benefit from taking part in this research? 
 You as a participant will not directly benefit from this project other than that the 
diagnosis will be double-checked. If successful, the routine diagnosis using this 
simpler and less traumatic cytology sampling method will be quicker, more cost 
effective and will cause less harm and risk to future patients with similar lesions.  
Can you sustain additional harm as result of your taking part in this research 
study? 
 No. There will be no risk for additional harm as the cytology method will sample 
cells from the same area that will be immediately biopsied thereafter.  
 
Are there any other risks involved in participating in this study?  
 No, absolutely not. You will bear no more risk other than that associated with the 
necessary tissue sampling biopsy procedure. We would like to reassure you that 
under no circumstances any extra tissue(s) will be harvested other than that is 
included in the standard biopsy procedure(s). 
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Who will have access to your medical records? 
 Only the investigators will keep a confidential laboratory logbook in which your 
absolute minimum data will be recorded e.g. the hospital number, age and surgical 
indication for the biopsy. All information collected for this research project will be 
coded and treated as confidential, and it will for instance be included in a thesis, a 
publication in a professional journal, etc, without disclosing your identity.   
Will you be paid to take part in this study and are there any costs involved? 
 No, you will not be paid to take part in the study and there will be no additional costs 
involved for you. The biopsy procedure and the routine histopathology examination 
are not part of this research project. 
 The results of this study can be explained to you by the researchers upon request. 
Is there anything else that you should know or do? 
 You can contact Prof Jos Hille (tel: 021-938 6159) or Prof Colleen Wright (tel: 021-
938 4048 at if you have any further queries or encounter any problems.  
 You can contact the US Health Research EsthicsCommittee at 021-938 9207  if you 
have any concerns or complaints that have not been adequately addressed by your 
study doctor.  
 You will receive a copy of this information and consent form for your own records. 
This study will be conducted according to the Declaration of Helsinki  
and the MRC and ICH guidelines. 
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Consent forms 
Declaration by Patient 
 
I (name) …………………….….,   by signing below and initializing each page of this consent 
form, agree to take part in the research study entitled: “Diagnostic accuracy of liquid-based 
brush cytology of upper aero-digestive tract mucosal dysplasia and malignancy” and declare 
that: 
 I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately answered. 
 I understand that taking part in this study is voluntary and I have not been pressurized by 
any person to take part. 
 I may choose to leave the study at any time and will not be penalised/ prejudiced in any 
way and my current and future treatment will not be negatively influenced. 
 I may be asked to leave the study before it has finished, if the study doctor and/or 
researchers feel it is in my best interests, or if I do not follow the study plan, as agreed to. 
 
Signed at (place)………………………………...on (date) ………/…………… /20.. 
 
…………………………..                                    ..……………………… 
Signature (or right thumb print)  Signature of Witness.  
Of Participant or representative                                  
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Declaration by Investigator 
 
I  (name )  …………………………………………………declare that:- 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as discussed 
above 
 I did/did not use a translator. (If a translator is used then the translator must sign the 
declaration below). 
 
Signed at (place)……………………………..on (date) ………/……………….. /20.. 
…………………………..                                  ……………………… 
Signature of Investigator                                     Signature of Witness.  
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Declaration by Translator   
 
I (name )  …………………………………………………declare that: 
 I assisted the investigator (name)…………………………. to explain the information in 
this document to (name of participant)…………………………….. Using the language 
medium of Afrikaans/Xhosa or ………….. (Other language). 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
